miR-200b as a prognostic factor targets multiple members of RAB family in glioma
- 30 January 2014
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 31 (3) , 1-8
Abstract
MiR-200b is a tumor suppressor in multiple tumors including gastric cancer, breast cancer, ovarian cancer and glioma. In this study, we detected the expression of miR-200b and analyzed its correlation with clinicopathological parameters in glioma tissues. miR-200b was downregulated in glioma tissues. And its downexpression was correlated with poor prognosis in gliomas. Members of RAB family, RAB21, RAB23, RAB18 and RAB3B were predicted to be novel targets of miR-200b. The direct suppression of RAB21, RAB23, RAB18 and RAB3B expressions by miR-200b was revealed by luciferase reporter assay, quantitative RT-PCR analysis and Western blot. Furthermore, the overall survival of patients with different expression of RABs was analyzed. The expression of RAB21, RAB23, RAB18 and RAB3B was related to the prognosis and histopathology of glioma. The patients who had the upregulation of all the four RABs had the worst outcome; those who had the downregulation of all RABs had the best outcome (p < 0.001). miR-200b was a potential biomarker for glioma prognosis.Keywords
This publication has 29 references indexed in Scilit:
- The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cellsInternational Journal of Oncology, 2013
- Epithelial–mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinomaJournal of Human Genetics, 2013
- miR-200b targets GATA-4 during cell growth and differentiationRNA Biology, 2013
- Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cellsCarcinogenesis, 2013
- Vacuolar H+ ATPase expression and activity is required for Rab27B‐dependent invasive growth and metastasis of breast cancerInternational Journal of Cancer, 2013
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patientsEndocrine-Related Cancer, 2010
- A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasionBritish Journal of Cancer, 2009
- Rab18 and Rab43 have key roles in ER-Golgi traffickingJournal of Cell Science, 2008
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2Journal of Biological Chemistry, 2008
- Characterization of Rab18, a Lipid Droplet–Associated Small GTPase2008